Giving yourself cancer medication at home instead of the hospital

This trial tested whether patients being treated for multiple myeloma could safely administer Carfilzomib—a cancer medication—to themselves at home on certain days, rather than always going to the hospital. Patients received their first doses at the hospital and learned to give themselves the medication at home on the days in between. The study explored whether this approach was safe, practical, and improved patients' quality of life.

Multiple myeloma treatment requires patients to visit the hospital many times each month for medication infusions, which takes a lot of time, increases exposure to hospital infections, and can be especially hard for people who live far away. This trial tested whether letting trained patients self-administer part of their treatment at home could reduce these burdens while keeping them safe.